Literature DB >> 21441843

Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas.

Hidenori Karasaki1, Yusuke Mizukami, Yoshihiko Tokusashi, Kazuya Koizumi, Akira Ishizaki, Kouji Imai, Daitaro Yoshikawa, Shuichi Kino, Junpei Sasajima, Satoshi Tanno, Kakuya Matsumoto, Naoyuki Miyokawa, Toru Kono, Yutaka Kohgo, Hiroyuki Furukawa.   

Abstract

OBJECTIVE: The aim of this study was to define the relevance of mural nodules (MNs) as a "direct" indicator of malignancy of intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
METHODS: Thirty-nine surgically resected IPMNs excluding obviously invasive carcinomas were examined. The distribution of the most severely dysplastic lesions was mapped on specimens. Immunohistochemical analysis for MUC1 and MUC2 was performed on sections containing the histologically predominant lesions and the most severely dysplastic areas.
RESULTS: The presence of MNs correlated well with the histological grade of IPMN (P < 0.01); however, the most severely dysplastic lesions were associated with a flat/nonelevated area rather than MNs (78.9%). In the MUC1-positive subgroup, minimally invasive carcinoma was colocalized to MNs, whereas most severely dysplastic foci including minimally invasive carcinoma with components of mucinous and tubular adenocarcinoma were observed in the areas apart from MNs in the MUC2-positive and MUC1/2-negative subgroups, respectively.
CONCLUSIONS: Although our data support the concept that MNs represent areas of higher-grade dysplasia within IPMN, development of invasive lesions from MNs may be limited to cases that are MUC1-positive. Careful attention should be paid to the emergence of invasive IPMN from flat foci in MUC2-positive and MUC1/2-negative cases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21441843     DOI: 10.1097/MPA.0b013e31820d1a03

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  4 in total

1.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

2.  Clinicopathological characterization of so-called "cholangiocarcinoma with intraductal papillary growth" with respect to "intraductal papillary neoplasm of bile duct (IPNB)".

Authors:  Yasuni Nakanuma; Yasunori Sato; Hidenori Ojima; Yae Kanai; Shinichi Aishima; Masakazu Yamamoto; Shun-ichi Ariizumi; Toru Furukawa; Hiroki Hayashi; Michiaki Unno; Tetsuo Ohta
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

3.  Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous Neoplasm.

Authors:  Krushna C Patra; Nabeel Bardeesy; Yusuke Mizukami
Journal:  Clin Transl Gastroenterol       Date:  2017-04-06       Impact factor: 4.488

Review 4.  Intraductal Pancreatic Mucinous Neoplasms: A Tumor-Biology Based Approach for Risk Stratification.

Authors:  Vincenzo Nasca; Marta Chiaravalli; Geny Piro; Annachiara Esposito; Lisa Salvatore; Giampaolo Tortora; Vincenzo Corbo; Carmine Carbone
Journal:  Int J Mol Sci       Date:  2020-09-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.